Want to see TSE:ASG full AI Analyst Report?
ASG Stock Chart & Stats
C$0.22
C$0.01(4.88%)
At close: 4:00 PM EDT
C$0.22
C$0.01(4.88%)
Day’s Range― - ―
52-Week RangeC$0.18 - C$0.33
Previous CloseN/A
Volume127.00
Average Volume (3M)30.19K
Market Cap
C$15.62M
Enterprise ValueC$12.84M
Total Cash (Recent Filing)C$778.55K
Total Debt (Recent Filing)C$2.26M
Price to Earnings (P/E)―
Beta0.33
Next Earnings
Aug 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding78,092,200
10 Day Avg. Volume38,837
30 Day Avg. Volume30,190
Financial Highlights & Ratios
PEG Ratio0.79
Price to Book (P/B)4.02
Price to Sales (P/S)0.83
P/FCF Ratio36.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Cash GenerationTrailing‑12‑month operating and free cash flow turning positive indicates the company is generating internal liquidity, reducing reliance on external financing. This durable improvement supports reinvestment, working capital stability and gives management flexibility over the next 2–6 months.
Manageable LeverageA low debt-to-equity ratio (~0.18) and positive equity provide a conservative capital structure that reduces solvency risk. This balance sheet health gives the company room to fund operations or targeted investments without high fixed interest burdens over the medium term.
Strong Gross And Improving EBITDA MarginsHigh gross margin and a positive EBITDA margin reflect durable unit economics and improving cost structure. Sustained margins support profitability as revenues recover and allow the company to invest in growth while maintaining operational resilience over the coming months.
Bears Say
Material Revenue DeclineA nearly 30% TTM revenue contraction signals weakened demand or execution issues that can persist absent structural fixes. Continued top-line pressure undermines scale benefits, limits margin expansion potential and constrains cash generation durability over the 2–6 month horizon.
Ongoing Net Losses And Negative ReturnsNet losses and significantly negative ROE demonstrate the company is not yet converting operations into shareholder returns. Persistent unprofitability erodes capital over time, limits reinvestment capacity and keeps funding needs elevated unless profitability trends reverse.
Very Small Operating ScaleA tiny employee base constrains commercial reach, R&D throughput and ability to scale sales and regulatory processes. Limited human capital raises execution risk for product rollout and market development, making growth and margin stabilization harder to sustain.
Aurora Spine News
ASG FAQ
What was Aurora Spine Corp’s price range in the past 12 months?
Aurora Spine Corp lowest stock price was C$0.18 and its highest was C$0.33 in the past 12 months.
What is Aurora Spine Corp’s market cap?
Aurora Spine Corp’s market cap is C$15.62M.
When is Aurora Spine Corp’s upcoming earnings report date?
Aurora Spine Corp’s upcoming earnings report date is Aug 26, 2026 which is in 19 days.
How were Aurora Spine Corp’s earnings last quarter?
Currently, no data Available
Is Aurora Spine Corp overvalued?
According to Wall Street analysts Aurora Spine Corp’s price is currently Overvalued.
Does Aurora Spine Corp pay dividends?
Aurora Spine Corp does not currently pay dividends.
What is Aurora Spine Corp’s EPS estimate?
Aurora Spine Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aurora Spine Corp have?
Aurora Spine Corp has 78,092,200 shares outstanding.
What happened to Aurora Spine Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aurora Spine Corp?
Currently, no hedge funds are holding shares in TSE:ASG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aurora Spine Corp
Established in 2013 and headquartered in Toronto, Canada, Aurora Spine Corporation, through its subsidiary Aurora Spine, Inc., specializes in the development and distribution of advanced, minimally invasive spinal fusion systems and devices within the Canadian market. The company offers a comprehensive portfolio of products designed to address various spinal conditions, particularly degenerative disc diseases. This includes interspinous process lumbar fusion devices such as the ZIP series (ZIP, ZIP ULTRA, ZIP LP, and ZIP-51). Aurora Spine also provides Ti-Coated polyether ether ketone (PEEK) interbody cages, which are crucial for maintaining space and stability between vertebrae while facilitating bone fusion. Its offerings extend to sterile-packed titanium plasma spray coated spinal fusion implants that promote bone growth. Key interbody products comprise EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar region, and Discovery for cervical applications. The company also manufactures SOLO, an anterior lumbar interbody fusion (ALIF) 3D-printed stand-alone device featuring an integrated plate and spacer system for anatomical preservation and spinal support. For sacroiliac joint issues, Aurora Spine provides SiLo, a posterior fusion device. Furthermore, the DEXA-C cervical interbody system, a porous 3D-printed intervertebral body fusion device with customizable lattice density options, is available to match patient bone quality.
Technical Analysis
Perimeter Medical Imaging AI
―
―
Theralase Technologies
―
VentriPoint Diagnostics
―
―